134 related articles for article (PubMed ID: 8683867)
1. [Chronic myelocytic leukemia associated with cytomegalovirus induced sialoadenitis after unrelated allogeneic bone marrow transplantation].
Yoshida M; Ueda S; Harano H; Yamazaki E; Kato K; Tanabe J; Okamoto R; Ogawa K; Mohri H; Okubo T; Sasaki S; Matsuzaki M; Nakatani Y; Chiba N
Rinsho Ketsueki; 1996 Jan; 37(1):46-52. PubMed ID: 8683867
[TBL] [Abstract][Full Text] [Related]
2. [Foscarnet therapy for ganciclovir-refractory cytomegalovirus hepatitis in a patient who underwent bone marrow transplantation from an unrelated donor].
Fujisaki T; Gondo H; Uchida N; Matsuo I; Takenaka K; Tanimoto K; Otsuka T; Minematsu T; Minamishima Y; Niho Y
Rinsho Ketsueki; 1997 Feb; 38(2):142-5. PubMed ID: 9059069
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of CMV retinitis with ganciclovir after allogeneic marrow transplantation.
Kaulfersch W; Urban C; Hauer C; Lackner H; Gamillscheg A; Slavc I; Langmann G
Bone Marrow Transplant; 1989 Sep; 4(5):587-9. PubMed ID: 2551437
[TBL] [Abstract][Full Text] [Related]
4. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir and standard high-dose immunoglobulins for the treatment of cytomegalovirus interstitial pneumonia in a bone marrow recipient.
Iori AP; Gentile G; Petasecca Donati P; Arcese W; Martino P; Mandelli F
Haematologica; 1990; 75(4):394-6. PubMed ID: 2177441
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation.
de Medeiros CR; Moreira VA; Pasquini R
Bone Marrow Transplant; 2000 Aug; 26(4):443-4. PubMed ID: 10982292
[TBL] [Abstract][Full Text] [Related]
8. Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-up.
Zaia JA; Schmidt GM; Chao NJ; Rizk NW; Nademanee AP; Niland JC; Horak DA; Lee J; Gallez-Hawkins G; Kusnierz-Glaz CR
Biol Blood Marrow Transplant; 1995 Dec; 1(2):88-93. PubMed ID: 9118297
[TBL] [Abstract][Full Text] [Related]
9. Pre-emptive ganciclovir treatment can play a role in restoration of hematopoiesis after allogeneic bone marrow transplantation.
Choi JH; Kim DW; Cho SG; Yoo JH; Jeong DC; Han CW; Shin WS; Min WS; Kim HK; Kim CC; Kim DJ
Bone Marrow Transplant; 1997 Jan; 19(2):187-90. PubMed ID: 9116619
[TBL] [Abstract][Full Text] [Related]
10. [A case of successful treatment with ganciclovir for cytomegalovirus pneumonia after pulmonary lobectomy].
Inaba H; Ohta S; Nishimura T; Takamochi K; Ishida I; Etoh T; Honda A; Nakajima H; Muro H; Nagashima Y
Kyobu Geka; 1997 Nov; 50(12):1004-8. PubMed ID: 9388344
[TBL] [Abstract][Full Text] [Related]
11. [Prophylaxis and treatment of cytomegalovirus infection in allogeneic bone marrow transplantation].
Guo N; Lu D; Liu D
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):402-4. PubMed ID: 11721418
[TBL] [Abstract][Full Text] [Related]
12. Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation.
Szer J; Durrant S; Schwarer AP; Bradstock KF; Gibson J; Arthur C; To LB; Hughes T; Raunow H
Intern Med J; 2004 Mar; 34(3):98-101. PubMed ID: 15030456
[TBL] [Abstract][Full Text] [Related]
13. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation.
Mori T; Okamoto S; Matsuoka S; Yajima T; Wakui M; Watanabe R; Ishida A; Iwao Y; Mukai M; Hibi T; Ikeda Y
Bone Marrow Transplant; 2000 Apr; 25(7):765-9. PubMed ID: 10745263
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection.
Einsele H; Hebart H; Kauffmann-Schneider C; Sinzger C; Jahn G; Bader P; Klingebiel T; Dietz K; Löffler J; Bokemeyer C; Müller CA; Kanz L
Bone Marrow Transplant; 2000 Apr; 25(7):757-63. PubMed ID: 10745262
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural changes in peripheral blood neutrophils in a patient receiving ganciclovir for CMV pneumonitis following allogenic bone marrow transplantation.
Ghosh K; Muirhead D; Christie B; Hiwase D
Bone Marrow Transplant; 1999 Aug; 24(4):429-31. PubMed ID: 10467335
[TBL] [Abstract][Full Text] [Related]
16. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
17. Late-onset herpes simplex virus-associated interstitial pneumonia after allogeneic bone marrow transplantation.
Kitabayashi A; Hirokawa M; Horiuchi T; Kawabata Y; Miura AB
Bone Marrow Transplant; 2000 Jan; 25(2):225-6. PubMed ID: 10673688
[No Abstract] [Full Text] [Related]
18. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
19. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT.
Trenschel R; Ross S; Hüsing J; Ottinger H; Elmaagacli A; Roggendorf M; Schaefer UW; Runde V
Bone Marrow Transplant; 2000 Mar; 25(6):665-72. PubMed ID: 10734302
[TBL] [Abstract][Full Text] [Related]
20. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
